Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model
Loading...
Date
Authors
Lysitsas, D. N.
Katsouras, C. S.
Papakostas, J. C.
Toumpoulis, I. K.
Angelidis, C.
Bozidis, P.
Thomas, C. G.
Seferiadis, K.
Psychoyios, N.
Frillingos, S.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Type
Type of the conference item
Journal type
peer-reviewed
Educational material type
Conference Name
Journal name
Cardiovasc Intervent Radiol
Book name
Book series
Book edition
Alternative title / Subtitle
Description
Experimental and clinical data suggest that stents eluting antiproliferative agents can be used for the prevention of in-stent restenosis. Here we investigate in vitro the antiproliferative and apoptotic effect of D-24851 and evaluate the safety and efficacy of D-24851-eluting polymer-coated stents in a rabbit restenosis model (n = 53). Uncoated stents (n = 6), poly (DL: -lactide-co-glycolide) (PLGA)-coated stents (n = 7), and PLGA-coated stents loaded with 0.08 +/- 0.0025 microM (31 +/- 1 mug; low dose; n = 7), 0.55 +/- 0.02 microM (216 +/- 8 mug; high dose; n = 6), and 4.55 +/- 0.1 microM (1774 +/- 39 mug; extreme dose; n = 5) of D-24851 were randomly implanted in New Zealand rabbit right iliac arteries and the animals were sacrificed after 28 days for histomorphometric analysis. For the assessment of endothelial regrowth in 90 days, 12 rabbits were subjected to PLGA-coated (n = 3), low-dose (n = 3), high-dose (n = 3), and extreme-dose (n = 3) stent implantation. In vitro studies revealed that D-24851 exerts its growth inhibitory effects via inhibition of proliferation and induction of apoptosis without increasing the expression of heat shock protein-70, a cytoprotective and antiapoptotic protein. Treatment with low-dose D-24851 stents was associated with a significant reduction in neointimal area and percentage stenosis only compared with bare metal stents (38% [P = 0.029] and 35% [P = 0.003] reduction, respectively). Suboptimal healing, however, was observed in all groups of D-24851-loaded stents in 90 days in comparison with PLGA-coated stents. We conclude that low-dose D-24851-eluting polymer-coated stents significantly inhibit neointimal hyperplasia at 28 days through inhibition of proliferation and enhancement of apoptosis. In view of the suboptimal re-endothelialization, longer-term studies are needed in order to establish whether the inhibition of intimal growth is maintained.
Description
Keywords
Acetamides/*pharmacology, Analysis of Variance, Animals, Apoptosis, Balloon Dilation/instrumentation, *Blood Vessel Prosthesis Implantation, Blotting, Western, Coated Materials, Biocompatible, Graft Occlusion, Vascular/*prevention & control, Hyperplasia, Iliac Artery/*surgery, Indoles/*pharmacology, Male, Microscopy, Electron, Scanning, Microscopy, Fluorescence, Models, Animal, Polymers, Prosthesis Design, Rabbits, Random Allocation, Stainless Steel, *Stents, Tunica Intima/*drug effects/pathology
Subject classification
Citation
Link
http://www.ncbi.nlm.nih.gov/pubmed/17828426
http://www.springerlink.com/content/642003146257w455/fulltext.pdf
http://www.springerlink.com/content/642003146257w455/fulltext.pdf
Language
en
Publishing department/division
Advisor name
Examining committee
General Description / Additional Comments
Institution and School/Department of submitter
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής